How were MusclePharm's earnings last quarter?

MusclePharm Co. (OTCMKTS:MSLP) announced its quarterly earnings results on Monday, August, 10th. The company reported ($0.51) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.19) by $0.32. The business had revenue of $50.48 million for the quarter, compared to analyst estimates of $55 million.

What other stocks do shareholders of MusclePharm own?

Based on aggregate information from My MarketBeat watchlists, some companies that other MusclePharm investors own include Dalradian Resources (DALR) , EVRAZ (EVRZF) , Rent-A-Center (RCII) , AdvanSix (ASIX) , Accuray (ARAY) , Apollo Global Management (APO) , TD Ameritrade (AMTD) , Alaska Communications Systems Group (ALSK) and Alnylam Pharmaceuticals (ALNY) .

How do I buy shares of MusclePharm?

Shares of MSLP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:MSLP

MusclePharm (MSLP) Stock Price, News & Analysis

→ Start loving Mondays like this (From DTI) (Ad)

Free MSLP Stock Alerts

Compare

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: N/A
Average Volume: 26,442 shs
Market Capitalization: $7,000.00

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Financials SEC Filings

Get MusclePharm alerts:

Ad WealthPress

Chances are you know the firms on this list

These are the entities that can buy MILLIONS of shares in a single day… I’m talking about huge orders that literally move the share price 1%, 2%, even 5% or more in the process. Why am I showing you that list? Well, because if you have a way to successfully detect which stocks these elite traders are likely buying in real time… All you have to do is ride the coattails of their massive orders and you can target endless trading opportunities without leaving your money exposed to the markets for too long. And in case you didn’t already know…

That’s exactly how this expert trader plans to trade his #1 ticker for 2024

About MusclePharm Stock (OTCMKTS:MSLP)

MusclePharm Corporation develops, manufactures, markets, and distributes sports nutrition products and nutritional supplements in the United States and internationally. The company offers a range of performance powders, capsules, tablets, gels, and on-the-go ready to eat snacks. Its MusclePharm brand product portfolio includes combat protein powder and combat crunch protein bars; and essential supplements, such as a BCAA, creatine, glutamine, carnitine, CLA, fish oil, multi-vitamin, and other products. The company also provides FitMiss branded sports nutrition products, which are formulated primarily for the female body to support women in the areas of weight management, lean muscle mass, body composition, and general health and wellness; and functional energy beverages under the Combat Energy and FitMiss Energy brands. It sells its products to various athletes and fitness enthusiasts. The company was incorporated in 2006 and is based in Las Vegas, Nevada.

Ad WealthPress

Chances are you know the firms on this list

That’s exactly how this expert trader plans to trade his #1 ticker for 2024

MSLP Stock News Headlines

February 24, 2024 | forbes.com

Best Protein Powder For Muscle Gain, According To Experts

February 11, 2024 | businessinsider.com

The 5 best muscle rubs of 2024

April 19, 2024 | DTI (Ad)

This company has increased its dividend every year for 54 years

There are three basic steps to building the Ultimate Dividend Portfolio. Step #1 is to Get The High Yields! So an index fund like the SPY, paying only 1.5% a year, isn’t going to cut it. But a company like Altria Group (MO) will.

November 2, 2023 | msn.com

7 Healthy Habits to Decrease the Risk of Breast Cancer

October 2, 2023 | msn.com

FitLife Brands swoops in for bankrupt MusclePharm assets

September 28, 2023 | msn.com

US Bankruptcy Court Approves FitLife's $18.5M Acquisition Of MusclePharm

September 27, 2023 | benzinga.com

FitLife Brands to Acquire Substantially All of the Assets of MusclePharm Corporation

July 9, 2023 | health.usnews.com

What Are the Best Foods for Building Muscle?

April 19, 2024 | DTI (Ad)

This company has increased its dividend every year for 54 years

April 6, 2023 | forbes.com

How To Build Muscle, According To Experts

March 20, 2023 | health.usnews.com

11 Benefits of Strength Training That Have Nothing to Do With Muscle Size

March 7, 2023 | health.usnews.com

Can You Gain Muscle While Losing Weight?

February 16, 2023 | foxnews.com

Electric Dodge muscle car spotted in 'Fast X' trailer

February 11, 2023 | uk.investing.com

Dae Hwa Pharm Co Ltd (067080)

December 23, 2022 | thestreet.com

Why MusclePharm (MSLP) Stock Is Up Today

July 6, 2022 | finance.yahoo.com

MusclePharm Announces the Launch of FitMiss Energy

June 23, 2022 | seekingalpha.com

MusclePharm Files For Uplisting IPO To Nasdaq

June 7, 2022 | seekingalpha.com

MusclePharm announces additional private placement of $2.5M senior secured notes

May 24, 2022 | finance.yahoo.com

MusclePharm to Present at the LD Micro Invitational XII Conference

May 16, 2022 | benzinga.com

MusclePharm Announces First Quarter 2022...

May 16, 2022 | seekingalpha.com

MusclePharm Corporation (MSLP) CEO Ryan Drexler on Q1 2022 Results - Earnings Call Transcript

May 16, 2022 | finance.yahoo.com

MusclePharm Announces First Quarter 2022 Financial Results

May 5, 2022 | morningstar.com

Correction: MusclePharm Announces Fourth Quarter and Fiscal Year 2021 Financial Results

April 14, 2022 | finance.yahoo.com

MusclePharm Announces Fourth Quarter and Fiscal Year 2021 Financial Results

April 12, 2022 | finance.yahoo.com

MusclePharm to Announce Fourth Quarter and Full Year 2021 Financial Results on Thursday, April 14, 2022

March 31, 2022 | finance.yahoo.com

MusclePharm Announces Launch into Ready-to-Drink Protein Category

March 11, 2022 | seekingalpha.com

MusclePharm releases preliminary Q421 results

See More Headlines

Receive MSLP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MusclePharm and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 8/10/2015
Today: 4/19/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Consumer Staples
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Current Symbol: OTCMKTS:MSLP
CUSIP: N/A
CIK: 1415684
Web: www.musclepharm.com
Phone: (800) 292-3909
Fax: N/A
Employees: 27
Year Founded: 2008

Profitability

EPS (Most Recent Fiscal Year): ($0.58)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-12,870,000.00
Net Margins: -38.51%
Pretax Margin: -38.52%
Return on Equity: N/A
Return on Assets: -169.56%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 0.25
Quick Ratio: 0.23

Sales & Book Value

Annual Sales: $50.04 million
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: ($0.94) per share
Price / Book: N/A

Miscellaneous

Outstanding Shares: 33,390,000
Free Float: 13,121,000
Market Cap: $7,000.00
Optionable: Not Optionable
Beta: -0.07

Social Links

The Best High-Yield Dividend Stocks for 2024

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

Mr. Ryan Charles Drexler (Age 51)
Exec. Chairman & CEO
Comp: $1.64M
John Mills Mills
Sr. Managing Director
Mr. Gary Charles Shirshac (Age 60)
Interim Chief Financial Officer
Mr. Eric Chin (Age 42)
Chief Accounting Officer & Director
Dr. Roscoe M. Moore Jr. (Age 77)
DSc, DVM, MPH, Ph.D., Chief Scientific Director & Member of Scientific Advisory Board
Mr. Mark E. Groussman (Age 49)
Consultant

Key Competitors

View All Competitors

MSLP Stock Analysis - Frequently Asked Questions

How were MusclePharm's earnings last quarter?: MusclePharm Co. (OTCMKTS:MSLP) announced its quarterly earnings results on Monday, August, 10th. The company reported ($0.51) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.19) by $0.32. The business had revenue of $50.48 million for the quarter, compared to analyst estimates of $55 million.
What other stocks do shareholders of MusclePharm own?: Based on aggregate information from My MarketBeat watchlists, some companies that other MusclePharm investors own include Dalradian Resources (DALR), EVRAZ (EVRZF), Rent-A-Center (RCII), AdvanSix (ASIX), Accuray (ARAY), Apollo Global Management (APO), TD Ameritrade (AMTD), Alaska Communications Systems Group (ALSK) and Alnylam Pharmaceuticals (ALNY).
How do I buy shares of MusclePharm?: Shares of MSLP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:MSLP) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial